Air India cancels US-bound flights again due to 5G rollout

"Dear Sir/Ma'am, Due to deployment of the 5G communications in USA, (AI106 EWR-DEL) will not be able to operate on 20th Jan'22. Next update will be informed shortly," Air India said in a tweet.

Moneycontrol News

January 20, 2022 / 10:14 IST

Air India has till now cancelled eight flights and six flights scheduled to operate on January 19 and January 20, respectively.

Air India has cancelled most of its flights flying to the US for the second day in a row due to the deployment of 5G internet in North America which could interfere with aircraft's navigation systems, the airline said in a series of replies to customers on Twitter on January 20th.

"Dear Sir/Ma'am, Due to deployment of the 5G communications in USA, (AI106 EWR-DEL) will not be able to operate on 20th Jan'22. Next update will be informed shortly," Air India said in a tweet.

Dear Sir/Ma'am, Due to deployment of the 5G communications in USA, (AI106 EWR-DEL) will not be able to operate on 20th Jan'22. Next update will be informed shortly.
— Air India (@airindiain) January 19, 2022

Air India has cancelled its flights from Delhi to Newark, Chicago and San Francisco that were scheduled to fly on January 20th, according to the airline's website.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show